Small-Molecule Inhibitors Allosterically Control Bruton's Tyrosine Kinase Assembly on the Membrane
Bruton's tyrosine kinase (Btk) is the target of small-molecule, active site inhibitors for treatment of lymphomas and leukemias. Beyond its catalytic activ